D. Işık

Publishing 2025

Is this you? Claim this profile
1
Article
263
Reads on Journament
59
Co-authors
1
Journal

This page collects the articles indexed under the name D. Işık. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.

Publications 1

  1. Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.
    S. Kahraman, E. Erul, O. Gumusay, D.C. Guven, Sercan Aksoy, G. Basaran, M. Seyyar, E. Sahin, D. Çabuk, E. Bayram, S. Paydaş, B. Demirel and 48 more
    clinical breast cancer 2025 263 reads

Possible papers by D. Işık 3

Published under a similar spelling of the name. Beside each paper is the evidence that it may be the same person, strongest first; "Same name only" means there is nothing else to go on.

  1. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
    as Deniz Işık BMC cancer 2023
    Shared co-author: Merve Keskinkılıç, Eda Eylemer Mocan
  2. Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience.
    as Deniz Işik Cancer investigation 2021
    Shared co-author: Mutlu Dogan
  3. Early neonatal outcomes of very-low-birth-weight infants in Turkey: A prospective multicenter study of the Turkish Neonatal Society.
    as Dilek Ulubas Isik PloS one 2019 Sağlık Bilimleri Üniversitesi
    Same name only

Under these spellings

Same person? Claim this profile, then add these papers one by one or combine a whole spelling.

Is this you?

Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.

Also published as

Tick the other spellings that are you. Leave the rest.

An admin reviews every claim. Your account's name, email address and affiliation are shown to them too.

You need an account to claim. No password: we email you a sign-in link, and your claim is sent as soon as you are back.

Frequent co-authors

Publishes in